Vir Biotechnology reports positive hepatitis delta trial data

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Vir Biotechnology reports positive hepatitis delta trial data
(NASDAQ: VIR) Delayed: 10.16 +0.59 (6.17%)
Previous Close $9.57    52 Week High $ 
Open $9.39    52 Week Low $ 
Day High $10.18    P/E N/A 
Day Low $9.39    EPS $ 
Volume 2,534,004